tiprankstipranks
Trending News
More News >

Rakovina Therapeutics Sets Date for Share Consolidation

Story Highlights
Rakovina Therapeutics Sets Date for Share Consolidation

Don’t Miss TipRanks’ Half-Year Sale

Rakovina Therapeutics Inc ( (TSE:RKV) ) has shared an update.

Rakovina Therapeutics Inc. has announced the effective date for its share consolidation, set for June 24, 2025, where one post-consolidation share will be issued for every ten pre-consolidation shares. The consolidation aims to streamline the company’s share structure, with the post-consolidation shares trading under the existing symbol ‘RKV’ on the TSX Venture Exchange, potentially impacting the company’s market positioning and shareholder value.

More about Rakovina Therapeutics Inc

Rakovina Therapeutics is a biopharmaceutical research company focused on developing innovative cancer treatments using unique technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI). The company aims to advance drug candidates into human clinical trials in collaboration with pharmaceutical partners.

Average Trading Volume: 421,358

Technical Sentiment Signal: Sell

Current Market Cap: C$11.61M

Find detailed analytics on RKV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1